From mean fluorescence intensity to C1q-Binding: The saga of Anti-HLA donor-specific antibodies

Transplantation

Volumn 99, Issue 6, 2015, Pages 1107-1108

  Loupy, Alexandre ^a   Legendre, Christophe ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; HLA ANTIBODY; ALLOANTIBODY; HLA ANTIGEN;

ANTIBODY MEDIATED REJECTION; ANTIGEN BINDING; HUMAN; MEAN FLUORESCENCE INTENSITY; MEDICAL PARAMETERS; NOTE; ORGAN DONOR; PRIORITY JOURNAL; SERUM; ADVERSE EFFECTS; BLOOD; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; METABOLISM;

COMPLEMENT C1Q; GRAFT REJECTION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION;

EID: 84930519715     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000700     Document Type: Note

References (10)

1. Loupy A, Lefaucheur C, Vernerey D, et al. Complement-binding anti-HLA antibodies and kidney-Allograft survival. N Engl J Med. 2013;369: 1215-1226.
2. Reed EF, Rao P, Zhang Z, et al. Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation. Am J Transplant. 2013;13:3050-3051.
3. Yabu JM, Higgins JP, Chen G, Sequeira F, Busque S, Tyan DB. C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation. 2011;91:342-347.
4. Sicard A, Ducreux S, Rabeyrin M, et al. Detection of C3d-binding donorspecific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. J Am Soc Nephrol. 2015;26:457-97.
5. Zeevi A, Lunz J, Feingold B, et al. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant. 2013;32:98-105.
6. Chin C, Chen G, Sequeria F, et al. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant. 2011;30:158-163.
7. Smith JD, Ibrahim MW, Newell H, et al. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation. J Heart Lung Transplant. 2014;33:1074-1082.
8. Ellis TM, Yell M, Muth BL, Kaufman DB, Djamali A. C1q-binding activity of de novo donor-specific HLA antibodies in renal transplant recipients with and without antibody-mediated rejection. Transplantation. 2015;99: 1151-1155.
9. Chen G, Sequeira F, Tyan DB. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol. 2011; 72:849-858.
10. Tait BD, Süsal C, Gebel HM, et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013;95:19-47.